Abridge, an AI-powered medical scribe company, has secured $300 million in Series E funding led by a16z, boosting its valuation to $5.3 billion. This comes just months after closing a $250 million Series D round. Abridge is recognised as a leader in the competitive AI medical scribe market, largely due to its early market entry and integration with Epic Systems, a leading health record software.
The company's technology converts patient-clinician conversations into structured clinical notes in real-time, streamlining documentation and reducing administrative burdens for healthcare providers. Abridge's rapid growth reflects the increasing adoption of AI in healthcare, with ambient AI technology becoming essential for medical practices. The company's solutions integrate into existing Electronic Health Record (EHR) systems, enhancing efficiency and accuracy in medical record-keeping. Abridge has raised approximately $800 million to date, including a $150 million Series C funding round in February 2024.
